Anzu Partners Fund III | 2024 VC Fund

Anzu Partners

cb Email

Status

ACTIVE

Global HQ

Washington, United States

Countries of investment

United States
Canada
United Kingdom
Germany
France
Netherlands
Israel
Australia
Japan
Singapore

Investment stages

Seed
Series A
Series B
Growth

Industries

Industrial Technology
Life Sciences
Clean Tech
Manufacturing
Materials Science
DeepTech
Semiconductors
MedTech
Biotech

About
Anzu Partners is a Washington-based venture capital and private equity firm focused on backing breakthrough industrial and life science technologies. Their focus spans industrial technology, life sciences, clean tech, manufacturing, and materials science across the United States, Canada, United Kingdom, Germany, France, Netherlands, Israel, Australia, Japan, and Singapore. The firm supports industrial tech founders from seed through growth stages.

Min check size: $1M
Max check size: $10M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Anzu Partners is a seed to growth stage venture capital and private equity firm deploying capital across industrial technology, life sciences, clean tech, manufacturing, and materials science sectors. They invest in breakthrough industrial and life science technologies, providing deep expertise in business development, market positioning, and operations. The firm differentiates itself through $1B+ AUM across venture, credit, and public structures, offering three distinct investment solutions and 60+ years of combined leadership experience.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Founded in 2014 by Whitney Haring-Smith (Managing Partner) and David Michael (Managing Partner). Team of 45+ professionals across investment, operations, finance, talent, PR, and legal functions. Recent additions include James "Hondo" Geurts and General Mike Murray as Venture Partners for the Anzu-Green Critical Technologies Fund. Manages $1B+ AUM across venture, credit, and public structures with three distinct investment solutions: early venture capital investments, growth debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). Operates from offices in Washington DC, San Diego, Boston, Atlanta, and Tampa. Portfolio includes Cyrus Biotechnology, South 8 Technologies, EnCharge AI, CytoTronics, Xendee, and Aspinity. The firm collaborates with entrepreneurs to develop and commercialize breakthrough industrial and life science technologies through capital and deep expertise in business development, market positioning, and operations.